Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Mechanism of intranasal drug delivery directly to the brain
Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Aryal, M., Arvanitis, C. D., Alexander, P. M., & McDannold, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.008 · Cited by 443
Intranasal drug delivery: An efficient and non-invasive route for systemic administration
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L.-J., Le Guen, M., Fischler, M., & Devillier, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.003 · Cited by 398
Current State of Nanoemulsions in Drug Delivery
Lovelyn, C., & Attama, A. A. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225075 · Cited by 411
In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles
Betzer, O., Perets, N., Angel, A., Motiei, M., Sadan, T., Yadid, G., Offen, D., & Popovtzer, R. (2017) · ACS Nano · doi:10.1021/acsnano.7b04495 · Cited by 404
Perets, N., Betzer, O., Shapira, R., Brenstein, S., Angel, A., Sadan, T., Ashery, U., Popovtzer, R., & Offen, D. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04148 · Cited by 382
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Mucoadhesive vs. mucopenetrating particulate drug delivery
Netsomboon, K., & Bernkop-Schnürch, A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.11.003 · Cited by 318
Meng, Q., Wang, A., Hua, H., Jiang, Y., Wang, Y., Mu, H., Wu, Z., & Sun, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151474 · Cited by 310
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 298
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.09.030 · Cited by 289
Neuroprotective Herbs for the Management of Alzheimer’s Disease
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021) · Biomolecules · doi:10.3390/biom11040543 · Cited by 236
Nanoemulsions — Advances in Formulation, Characterization and Applications in Drug Delivery
Chime, S. A., Kenechukwu, F. C., & Attama, A. A. (2014) · Application of Nanotechnology in Drug Delivery · doi:10.5772/58673 · Cited by 217
Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy
Fan, R., Cheng, Y., Wang, R., Zhang, T., Zhang, H., Li, J., Song, S., & Zheng, A. (2022) · Polymers · doi:10.3390/polym14122379 · Cited by 225
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
Meredith, M. E., Salameh, T. S., & Banks, W. A. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9719-7 · Cited by 225
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 209
Liu, Z., Jiang, M., Kang, T., Miao, D., Gu, G., Song, Q., Yao, L., Hu, Q., Tu, Y., Pang, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.003 · Cited by 217
Haque, S., Md, S., Sahni, J. K., Ali, J., & Baboota, S. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.10.011 · Cited by 217
Correia, A. C., Monteiro, A. R., Silva, R., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 206
Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
Fortuna, A., Alves, G., Serralheiro, A., Sousa, J., & Falcão, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.004 · Cited by 211
Self-citationNose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C., Moreira, J. N., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 210
Ayurvedic medicinal plants for Alzheimer’s disease: A review
Rao, R. V., Descamps, O., John, V., & Bredesen, D. E. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt125 · Cited by 213
Vigani, B., Rossi, S., Sandri, G., Bonferoni, M. C., Caramella, C. M., & Ferrari, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090859 · Cited by 188
Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
Crowe, T. P., & Hsu, W. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030629 · Cited by 183
Bitter, C., Suter-Zimmermann, K., & Surber, C. (2011) · Current Problems in Dermatology · doi:10.1159/000321044 · Cited by 198
Intranasal Insulin for Alzheimer’s Disease
Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 177
Development of in situ gel for nasal delivery: design, optimization,in vitro and in vivo evaluation
Galgatte, U. C., Kumbhar, A. B., & Chaudhari, P. D. (2014) · Drug Delivery · doi:10.3109/10717544.2013.849778 · Cited by 174
Nose-to-brain peptide delivery – The potential of nanotechnology
Samaridou, E., & Alonso, M. J. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 178
Amphiphilic block copolymers in drug delivery: advances in formulation structure and performance
Bodratti, A. M., & Alexandridis, P. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1529756 · Cited by 180
A slippery slope: On the origin, role and physiology of mucus
Taherali, F., Varum, F., & Basit, A. W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.014 · Cited by 172
A review of intranasal formulations for the treatment of seizure emergencies
Kapoor, M., Cloyd, J. C., & Siegel, R. A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.001 · Cited by 167
Nasal-nanotechnology: revolution for efficient therapeutics delivery
Kumar, A., Pandey, A. N., & Jain, S. K. (2016) · Drug Delivery · doi:10.3109/10717544.2014.920431 · Cited by 170
Recent trends in vaccine delivery systems: A review
Lakshmi, P., Bhaskaran, S., & Saroja, C. (2011) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.82384 · Cited by 161
Nasal route for vaccine and drug delivery: Features and current opportunities
Lobaina, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118813 · Cited by 165
Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation
Haque, S., Md, S., Fazil, M., Kumar, M., Sahni, J. K., Ali, J., & Baboota, S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.02.051 · Cited by 164
Haumann, R., Videira, J. C., Kaspers, G. J. L., van Vuurden, D. G., & Hulleman, E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00766-w · Cited by 170
Mucosal vaccine delivery: Current state and a pediatric perspective
Shakya, A. K., Chowdhury, M. Y. E., Tao, W., & Gill, H. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.014 · Cited by 169
Long, Y., Yang, Q., Xiang, Y., Zhang, Y., Wan, J., Liu, S., Li, N., & Peng, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104795 · Cited by 151
Farr, A. C., & Xiong, M. P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 155
Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery
Alex, A. T., Joseph, A., Shavi, G. V., Rao, J. V., & Udupa, N. (2014) · Drug Delivery · doi:10.3109/10717544.2014.948643 · Cited by 151
Awad, R., Avital, A., & Sosnik, A. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.003 · Cited by 154
Kashyap, K., & Shukla, R. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191029122740 · Cited by 149
Piazzini, V., Landucci, E., D’Ambrosio, M., Fasiolo, L. T., Cinci, L., Colombo, G., Pellegrini-Giampietro, D. E., Bilia, A. R., Luceri, C., & Bergonzi, M. C. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.005 · Cited by 147
Pramanik, S., Mohanto, S., Manne, R., Rajendran, R. R., Deepak, A., Edapully, S. J., Patil, T., & Katari, O. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00491 · Cited by 145
Opportunity and challenges of nasal powders: Drug formulation and delivery
Fasiolo, L. T., Manniello, M. D., Tratta, E., Buttini, F., Rossi, A., Sonvico, F., Bortolotti, F., Russo, P., & Colombo, G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.09.027 · Cited by 144
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Rabiee, N., Ahmadi, S., Afshari, R., Khalaji, S., Rabiee, M., Bagherzadeh, M., Fatahi, Y., Dinarvand, R., Tahriri, M., Tayebi, L., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000076 · Cited by 154
Nour, S. A. E.-K., Abdelmalak, N. S., Naguib, M. J., Rashed, H. M., & Ibrahim, A. B. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1223216 · Cited by 142
Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment
Cristiano, C., Volpicelli, F., Lippiello, P., Buono, B., Raucci, F., Piccolo, M., Iqbal, A. J., Irace, C., Miniaci, M. C., Perrone‐Capano, C., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14586 · Cited by 148
Physicochemical and physiological considerations for efficient nose-to-brain targeting
Bahadur, S., & Pathak, K. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.636801 · Cited by 142
Md, S., Bhattamisra, S. K., Zeeshan, F., Shahzad, N., Mujtaba, M. A., Meka, V. S., Radhakrishnan, A. K., Kesharwani, P., Baboota, S., & Ali, J. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.09.022 · Cited by 148
Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa
Pund, S., Rasve, G., & Borade, G. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.029 · Cited by 137
Dua, K., Malyla, V., Singhvi, G., Wadhwa, R., Krishna, R. V., Shukla, S. D., Shastri, M. D., Chellappan, D. K., Maurya, P. K., Satija, S., et al. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.12.009 · Cited by 130
Nose-to-brain drug delivery: from bench to bedside
Drath, I., Richter, F., & Feja, M. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00481-w · Cited by 146
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion
Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.030 · Cited by 124
Bruinsmann, F. A., Vaz, G. R., Alves, A. D. C. S., Aguirre, T. A. S., Pohlmann, A. R., Guterres, S. S., & Sonvico, F. (2019) · Molecules · doi:10.3390/molecules24234312 · Cited by 134
Advances in intranasal vaccine delivery: A promising non-invasive route of immunization
Kehagia, E., Papakyriakopoulou, P., & Valsami, G. N. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.05.011 · Cited by 123
Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route
Mittal, D., Md, S., Hasan, Q., Fazil, M., Ali, A., Baboota, S., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.907372 · Cited by 121
Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies
Rojanarat, W., Changsan, N., Tawithong, E., Pinsuwan, S., Chan, H., & Srichana, T. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12074414 · Cited by 120
Nazar, H., Fatouros, D. G., van der Merwe, S. M., Bouropoulos, N., Avgouropoulos, G., Tsibouklis, J., & Roldo, M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.022 · Cited by 119
Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery
Salatin, S., Barar, J., Barzegar-Jalali, M., Adibkia, K., Milani, M. A., & Jelvehgari, M. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0782-0 · Cited by 118
Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery
Lungare, S., Hallam, K., & Badhan, R. K. S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.042 · Cited by 118
Jazuli, I., Annu, Nabi, B., Moolakkadath, T., Alam, T., Baboota, S., & Ali, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.001 · Cited by 117
Chung, S. S., Peters, J. M., Detyniecki, K., Tatum, W. O., Rabinowicz, A. L., & Carrazana, E. J. (2022) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2022.100581 · Cited by 124
Fan, Y., Chen, M., Zhang, J., Maincent, P., Xia, X., & Wu, W. (2018) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2018024697 · Cited by 115
Lofts, A., Abu-Hijleh, F. A., Rigg, N., Mishra, R. K., & Hoare, T. R. (2022) · CNS Drugs · doi:10.1007/s40263-022-00930-4 · Cited by 132
Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles
Luppi, B., Bigucci, F., Cerchiara, T., & Zecchi, V. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.495981 · Cited by 109
Strategies to facilitate or block nose-to-brain drug delivery
Martins, P. P., Smyth, H. D. C., & Cui, Z. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118635 · Cited by 106
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
Tai, J., Han, M. S., Lee, D., Park, I., Lee, S. H., & Kim, T. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051073 · Cited by 111
Vaccines, adjuvants and key factors for mucosal immune response
Correa, V. A., Portilho, A. I., & Gaspari, E. D. (2022) · Immunology · doi:10.1111/imm.13526 · Cited by 109
Ahmad, A., Mubarak, N. M., Naseem, K., Tabassum, H., Rizwan, M., Najda, A., Kashif, M., Bin-Jumah, M. N., Hussain, A., Shaheen, A., et al. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.10.019 · Cited by 107
Intranasal administration of carbamazepine to mice: A direct delivery pathway for brain targeting
Serralheiro, A., Alves, G., Fortuna, A. C., & Falcão, A. C. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.019 · Cited by 102
Self-citationTlaxca, J. L., Ellis, S., & Remmele, R. L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.002 · Cited by 102
(2011) · Research in Biotechnology · Cited by 101
Intranasal therapeutic strategies for management of Alzheimer’s disease
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2013.876644 · Cited by 99
Intranasal formulations: promising strategy to deliver vaccines
Riese, P., Sakthivel, P., Trittel, S., & Guzmán, C. A. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.931936 · Cited by 98
Ahmad, N. (2017) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2017.1343735 · Cited by 98
Emami, A., Tepper, J., Short, B. G., Yaksh, T. L., Bendele, A. M., Ramani, T., Cisternas, A. F., Chang, J., & Mellon, R. D. (2017) · International Journal of Toxicology · doi:10.1177/1091581817741840 · Cited by 100
How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods
Salade, L., Wauthoz, N., Goole, J., & Amighi, K. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.026 · Cited by 97
A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases
Wang, Y., Jiang, S., Wang, H., & Bie, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189478 · Cited by 102
Intranasal drug delivery for treatment of Alzheimer’s disease
Fonseca, L., Lopes, J. A., Vieira, J., Viegas, C., Oliveira, C. S., Hartmann, R. P., & Fonte, P. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00940-7 · Cited by 94
Rech, M. A., Barbas, B., Chaney, W., Greenhalgh, E., & Turck, C. J. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.02.015 · Cited by 92
Pérez‐Ruixo, C., Rossenu, S., Zannikos, P., Nandy, P., Singh, J. B., Drevets, W. C., & Ruixo, J. J. P. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00953-4 · Cited by 92
Intranasal delivery of stem cells to the brain
Jiang, Y., Zhu, J., Xu, G., & Liu, X. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566267 · Cited by 99
Chauhan, P., Singh, D. K., Dash, D., & Singh, R. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.022 · Cited by 88
Jnaidi, R., Almeida, A. J., & Gonçalves, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090860 · Cited by 89
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
Alabsi, W., Eedara, B. B., Encinas-Basurto, D., Polt, R. L., & Mansour, H. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091870 · Cited by 91
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
Leandro, K., Bicker, J., Alves, G., Falcão, A. C., & Fortuna, A. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.031 · Cited by 90
Self-citationChallenges of BDNF-based therapies: From common to rare diseases
Miranda‐Lourenço, C., Ribeiro‐Rodrigues, L., Fonseca‐Gomes, J., Tanqueiro, S. R., Belo, R. F., Ferreira, C. B., Rei, N., Ferreira-Manso, M., de Almeida-Borlido, C., Costa-Coelho, T., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105281 · Cited by 88
Costa, C. P., Barreiro, S., Moreira, J. N., Silva, R. V. D. S., Almeida, H., Lobo, J. M. S., & Silva, A. C. (2021) · Pharmaceuticals · doi:10.3390/ph14080711 · Cited by 86
Mucoadhesivein situnasal gelling drug delivery systems for modulated drug delivery
Singh, R. M. P., Kumar, A., & Pathak, K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.746659 · Cited by 87
Natesto ™ , a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men
Rogol, A. D., Tkachenko, N., & Bryson, N. (2015) · Andrology · doi:10.1111/andr.12137 · Cited by 89
Witika, B. A., Poka, M., Demana, P. H., Matafwali, S. K., Melamane, S., Khamanga, S. M., & Makoni, P. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040836 · Cited by 87
Advanced formulations for intranasal delivery of biologics
Rohrer, J., Lupo, N., & Bernkop‐Schnürch, A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.029 · Cited by 85
Intranasal curcumin and its evaluation in murine model of asthma
Subhashini, Chauhan, P., Kumari, S., Kumar, J. P., Chawla, R., Dash, D., Singh, M., & Singh, R. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.08.008 · Cited by 82
Candesartan ameliorates brain inflammation associated with Alzheimer's disease
Torika, N., Asraf, K., Apte, R. N., & Fleisher‐Berkovich, S. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12802 · Cited by 86
The nasal delivery of nanoencapsulated statins – an approach for brain delivery
Clementino, A., Batger, M., Garrastazu, G., Pozzoli, M., Del Favero, E., Rondelli, V., Gutfilen, B., Barboza, T., Sukkar, M. B., Souza, S. A. L., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s119033 · Cited by 81
Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery
Alavi, S., Haeri, A., & Dadashzadeh, S. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.10.063 · Cited by 90
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.